NBIX icon

Neurocrine Biosciences
NBIX

Overview Fund Activity

121 hedge funds and large institutions have $1.12B invested in Neurocrine Biosciences in 2014 Q1 according to their latest regulatory filings, with 31 funds opening new positions, 54 increasing their positions, 23 reducing their positions, and 26 closing their positions.

Holders
121
Holders Change
+4
Holders Change %
+3.42%
% of All Funds
3.5%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
31
Increased
54
Reduced
23
Closed
26
Calls
$10.4M
Puts
$7.04M
Net Calls
+$3.37M
Net Calls Change
-$1.83M

Top Buyers

1
O
1
OrbiMed
New York
$87.8M
2
Fidelity Investments
2
Fidelity Investments
Massachusetts
$182M
3
RCM
3
RA Capital Management
Massachusetts
$18.8M
4
BA
4
BlackRock Advisors
Delaware
$17.1M
5
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$165M

Top Sellers

1
Invesco
1
Invesco
Georgia
$11K
2
State Street
2
State Street
Massachusetts
$36.1M
3
Millennium Management
3
Millennium Management
New York
$0
4
VM
4
VHCP Management
New York
$4.89M
5
Deutsche Bank
5
Deutsche Bank
Germany
$11.9M
Name Holding Trade Value Shares
Change 		Shares
Change %
AQR Capital Management
26
AQR Capital Management
Connecticut
$7.33M +$1.45M +90,164 +25%
BBA
27
Baker Bros. Advisors
New York
$7.21M +$7.21M +447,874 New
AAMU
28
Amundi Asset Management US
Massachusetts
$7M -$1.45M -90,009 -17%
TCM
29
Tekla Capital Management
Massachusetts
$6.89M – – –
Geode Capital Management
30
Geode Capital Management
Massachusetts
$6.53M +$1.51M +93,806 +30%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$5.91M +$298K +18,518 +5%
Axa
32
Axa
France
$4.95M -$512K -31,813 -9%
VM
33
VHCP Management
New York
$4.89M -$6.3M -391,400 -56%
RSCM
34
Rock Springs Capital Management
Maryland
$4.83M +$4.83M +300,000 New
TCIM
35
TIAA CREF Investment Management
New York
$4.73M +$121K +7,511 +3%
Allianz Asset Management
36
Allianz Asset Management
Germany
$4.53M +$886K +55,000 +24%
BG
37
BlackRock Group
United Kingdom
$4.01M +$3.73M +231,830 +1,355%
CS
38
Credit Suisse
Switzerland
$3.84M +$396K +24,603 +11%
EMFAT
39
Emerald Mutual Fund Advisers Trust
Pennsylvania
$3.84M +$3.84M +238,560 New
EA
40
Emerald Advisers
Pennsylvania
$3.84M +$3.84M +238,410 New
Lord, Abbett & Co
41
Lord, Abbett & Co
New Jersey
$3.82M +$3.82M +237,141 New
GC
42
Guggenheim Capital
Illinois
$3.64M -$439K -27,244 -11%
TD Asset Management
43
TD Asset Management
Ontario, Canada
$3.49M +$634K +39,400 +22%
BIM
44
BlackRock Investment Management
Delaware
$3.35M +$394K +24,444 +13%
Charles Schwab
45
Charles Schwab
California
$3.02M +$78.8K +4,892 +3%
QBFM
46
QS Batterymarch Financial Management
New York
$2.77M -$1.6M -99,630 -37%
JPMorgan Chase & Co
47
JPMorgan Chase & Co
New York
$2.26M +$200K +12,450 +10%
California State Teachers Retirement System (CalSTRS)
48
California State Teachers Retirement System (CalSTRS)
California
$2.21M +$262K +16,300 +13%
Adage Capital Partners
49
Adage Capital Partners
Massachusetts
$2.19M +$2.19M +136,286 New
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$2.03M +$951K +59,059 +88%
1
2
3 4 5